Browsing by Yonsei Author : Rha, Sun Young

eperson profile image
Name:
Rha, Sun Young [라선영]
orcid http://orcid.org/0000-0002-2512-4531
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7006023235)

Keyword Cloud

Researcher Network

Showing results 101 to 150 of 526

This table browses all dspace content
Issue DateTitleJournal Title
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
2019Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. GASTRIC CANCER
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial CANCER RESEARCH AND TREATMENT
2018Screening audit' as a quality assurance tool in good clinical practice compliant research environments BMC MEDICAL ETHICS
2018A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer BMC CANCER
2018Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) KIDNEY CANCER(Kidney Cancer)
2018Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition CANCERS
2018Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinomaBRITISH JOURNAL OF CANCER
2018Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy BMC CANCER
2018Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
2018Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric CancerANTICANCER RESEARCH
2018Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" TrialCLINICAL CANCER RESEARCH
2018CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer YONSEI MEDICAL JOURNAL
2018BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2018Reconsideration of sample size and power calculation for overall survival in cancer clinical trials CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
2018MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.JOURNAL OF SURGICAL ONCOLOGY
2018Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. CANCER RESEARCH AND TREATMENT
2018Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)GASTRIC CANCER
2018Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC TrialANNALS OF SURGICAL ONCOLOGY
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and ChemotherapyAAPS JOURNAL
2018The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 statusGASTRIC CANCER
2018Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. KOREAN JOURNAL OF INTERNAL MEDICINE
2018Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitorINTERNATIONAL JOURNAL OF CANCER
2018Rab25 augments cancer cell invasiveness through a beta1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin EXPERIMENTAL AND MOLECULAR MEDICINE
2018The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea ControlCANCER NURSING
2018Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. BMC CANCER
2017Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trialLANCET ONCOLOGY
2017A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinomaANNALS OF ONCOLOGY
2017PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer ONCOTARGET
2017A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumorsINVESTIGATIONAL NEW DRUGS
2017A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCH
2017Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancerCLINICAL & TRANSLATIONAL ONCOLOGY
2017Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaCANCER DISCOVERY
2017Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC ANNALS OF ONCOLOGY
2017Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell CarcinomaCLINICAL GENITOURINARY CANCER
2017Symptom clusters during palliative chemotherapy and their influence on functioning and quality of lifeSUPPORTIVE CARE IN CANCER
2017Characterizing the outcomes of metastatic papillary renal cell carcinomaCANCER MEDICINE
2017Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer ONCOTARGET
2017Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancerBRITISH JOURNAL OF SURGERY
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer ONCOLOGY LETTERS
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer ONCOTARGET
2017Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell linesBIOCHEMICAL PHARMACOLOGY
2017Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients AMERICAN JOURNAL OF CANCER RESEARCH
2017ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibitionBIOCHEMICAL PHARMACOLOGY
2017Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcomaAPMIS
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia ANNALS OF SURGERY
2017Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted AgentsCLINICAL NUCLEAR MEDICINE
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer BMC CANCER
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab ONCOTARGET

Browse

Links